Further Implications of Off-Label Use of Acetazolamide in the Management of Moyamoya Disease in Japan

Radiology. 2017 Jul;284(1):301-303. doi: 10.1148/radiol.2017170252.
No abstract available

Publication types

  • Comment

MeSH terms

  • Acetazolamide*
  • Cerebrovascular Circulation
  • Humans
  • Japan
  • Moyamoya Disease*
  • Off-Label Use

Substances

  • Acetazolamide